RxDoctor Payments DataLook up a doctor →

Ayme Rowland, APRN

Family · Bowling Green, KYNPI 1366905242

Payments from drug & device makers

$13,970in general payments, 2019–2025

Across 626 payments — averaging $22.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Pfizer$1K
  • Novartis$1K
  • Johnson & Johnson$741
  • Daiichi Sankyo Inc.$658
  • AbbVie$504
  • plus $8K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)48$1,225
Pfizer61$1,014
Novartis62$1,013
Johnson & Johnson(2 entities)27$741
Daiichi Sankyo Inc.24$658
AbbVie20$504
Takeda Pharmaceuticals U.S.A., Inc.18$479
Genentech USA, Inc.16$463
Bristol Myers Squibb18$406
Astellas Pharma US Inc11$383
Merck22$371
Incyte Corporation16$361
E.r. Squibb & Sons, L.L.C.18$313
Sanofi11$303
Seagen Inc.7$295
GSK15$265
Gilead9$260
Bayer12$241
Regeneron Healthcare Solutions, Inc.8$234
Lilly USA, LLC11$212
Pharmaessentia USA Corporation7$199
Genmab U.S., Inc.8$198
Novo Nordisk4$179
Tersera Therapeutics LLC8$173
Amgen9$165
EMD Serono, Inc.6$157
Karyopharm Therapeutics Inc.7$155
Pharmacosmos Therapeutics Inc.8$149
Rigel Pharmaceuticals, Inc.6$138
Geron Corporation4$132
Kyowa Kirin, Inc.7$131
Exelixis Inc.5$131
Beone Medicines USA, Inc.3$119
ADC Therapeutics America, Inc.6$110
Eisai Inc.6$105
Sobi, Inc4$97
Puma Biotechnology, Inc.5$96
Dexcom, Inc.5$84
Springworks Therapeutics, Inc.4$76
Octapharma USA, Inc.3$76
Agios Pharmaceuticals, Inc.4$72
Stemline Therapeutics Inc.4$70
Blueprint Medicines Corporation3$68
Ipsen Biopharmaceuticals, Inc4$66
Array Biopharma Inc4$63
Celltrion USA Inc.2$62
Coherus Oncology, Inc.3$59
Sanofi-aventis U.S. LLC2$57
Mirati Therapeutics, Inc.3$53
Taiho Oncology, Inc.2$53
AVEO Pharmaceuticals, Inc.3$51
Morphosys, US Inc.2$49
Beigene USA, Inc.3$49
Sumitomo Pharma America, Inc.2$44
Sun Pharmaceutical Industries Inc.2$43
Nestle Healthcare Nutrition Inc.2$42
Phathom Pharmaceuticals, Inc.1$40
Recordati_rare_diseases_inc.2$36
Iovance Biotherapeutics, Inc.1$34
HEMA Biologics, LLC1$30

How this compares

$13,970 in reported general payments places this provider in the 95th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky →

Medicare billing

Part B allowed, 2024
$1,923,072
Medicare patients
348
Services billed
115,848

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Bowling Green

See the full list for Kentucky →

Where these figures come from

Is this you, or does something look wrong? →